Evidence map›Paper›PMID 29238712›Full record

ArticleBioMed research international2017

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the

Jon-Magnus Tangen, Toril Holien, Mohammad Reza Mirlashari, Kristine Misund, Geir Hetland

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Isolation and Identification of Chemical Compounds fromMolecules (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Agaritine derived fromFujita medical journal · 2023
    Article
  4. Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression.Journal of fungi (Basel, Switzerland) · 2021
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jon-Magnus TangenDepartment of Acute Medicine, Oslo University Hospital, Ullevål, Kirkeveien 166, 0407 Oslo, Norway.ORCID 0000-0003-4290-7746
Toril HolienDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), St. Olav's University Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, Norway.
Mohammad Reza MirlashariDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Ullevål, Kirkeveien 166, 0407 Oslo, Norway.
Kristine MisundDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), St. Olav's University Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, Norway.
Geir HetlandInstitute of Clinical Medicine, University of Oslo, P.O. Box 1171, 0318 Oslo, Norway.ORCID 0000-0003-1272-3436
Oslo University Hospital · NONorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgaricalesAgaricusCell Cycle CheckpointsCell Line, TumorComplex MixturesHumansLeukemiaMultiple MyelomaAndoSanComplex Mixtures

Identifiers

PMID29238712
PMCPMC5697368
OpenAlexW2768005394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.